Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
40 hedge funds and large institutions have $9.73M invested in Acer Therapeutics Inc in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 4 closing their positions.
17% more capital invested
Capital invested by funds: $8.34M → $9.73M (+$1.39M)
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0% more funds holding
Funds holding: 40 → 40 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$209K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$122K |
| 3 |
JP Morgan Chase
New York
|
+$57.8K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$38.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$320K |
| 2 |
JGC
J. Goldman & Co
New York
|
-$269K |
| 3 |
Goldman Sachs
New York
|
-$174K |
| 4 |
State Street
Boston,
Massachusetts
|
-$132K |
| 5 |
Millennium Management
New York
|
-$48K |
ACER Hedge Fund Activity: Q4 2019 in Review
40 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q4 2019, worth a combined $9.73M — up 17% from $8.34M a quarter earlier.
Fund positioning in ACER was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 14 added to existing stakes and 13 trimmed.
The largest buyer was Federated Hermes, adding an estimated $209K. The largest seller was Stonepine Capital Management, cutting an estimated $320K.
- 40 institutional investors held Acer Therapeutics Inc (ACER) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $9.73M of Acer Therapeutics Inc stock for Q4 2019, up 17% quarter-over-quarter.
- 4 funds opened new Acer Therapeutics Inc positions in Q4 2019 and 4 closed out, a net change of 0 holders.
- The largest Acer Therapeutics Inc buyer in Q4 2019 was Federated Hermes, an estimated $209K added.
- The largest Acer Therapeutics Inc seller in Q4 2019 was Stonepine Capital Management, an estimated $320K sold.
Based on aggregated 13F filings for Q4 2019.